ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,702.55
-0.19%
Dow Jones
42,063.36
0.09%
US Dollar vs MXN
19.4148
0.00%
Brent Oil
74.135
0.00%
Bitcoin
62,919.41
-0.72%
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Fortress Biotech Inc (FBIO)

  7. Fortress Biotech Inc (FBIO) Noticias

FBIO

Fortress Biotech (FBIO)

Fortress Biotech Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:FBIO
FechaHoraFuenteTítuloSímboloCompañía
20/09/202407:30GlobeNewswire Inc.Fortress Biotech Announces Pricing of $8 Million Registered Direct Offering and Concurrent Private PlacementsNASDAQ:FBIOFortress Biotech Inc
09/09/202407:30GlobeNewswire Inc.Journey Medical Corporation to Participate in the Lake Street Capital Markets 8th Annual Best Ideas Growth (BIG) ConferenceNASDAQ:FBIOFortress Biotech Inc
04/09/202407:30GlobeNewswire Inc.Fortress Biotech to Present at the H.C. Wainwright 26th Annual Global Investment ConferenceNASDAQ:FBIOFortress Biotech Inc
04/09/202407:15GlobeNewswire Inc.Journey Medical Corporation to Present at the H.C. Wainwright 26th Annual Global Investment ConferenceNASDAQ:FBIOFortress Biotech Inc
03/09/202407:30GlobeNewswire Inc.Avenue Therapeutics to Participate in Upcoming Investor ConferencesNASDAQ:FBIOFortress Biotech Inc
13/08/202415:05GlobeNewswire Inc.Fortress Biotech Reports Second Quarter 2024 Financial Results and Recent Corporate HighlightsNASDAQ:FBIOFortress Biotech Inc
12/08/202415:01GlobeNewswire Inc.Journey Medical Corporation Reports Second Quarter 2024 Financial Results and Recent Corporate HighlightsNASDAQ:FBIOFortress Biotech Inc
09/08/202415:05GlobeNewswire Inc.Avenue Therapeutics Reports Second Quarter 2024 Financial Results and Recent Corporate HighlightsNASDAQ:FBIOFortress Biotech Inc
06/08/202415:01GlobeNewswire Inc.Journey Medical Corporation to Announce Second Quarter 2024 Financial Results on August 12, 2024NASDAQ:FBIOFortress Biotech Inc
25/07/202407:30GlobeNewswire Inc.Fortress Biotech Reduces Total Debt and Enters into New $35 Million Term Loan with Oaktree with Maturity in 2027NASDAQ:FBIOFortress Biotech Inc
11/07/202415:05GlobeNewswire Inc.Journey Medical Corporation Appoints Michael C. Pearce to Board of DirectorsNASDAQ:FBIOFortress Biotech Inc
05/07/202415:05GlobeNewswire Inc.Fortress Biotech Announces Pause in Payment of Dividends on 9.375% Series A Cumulative Redeemable Perpetual Preferred StockNASDAQ:FBIOFortress Biotech Inc
21/06/202415:01GlobeNewswire Inc.Mustang Bio Announces Closing of $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq RulesNASDAQ:FBIOFortress Biotech Inc
20/06/202407:30GlobeNewswire Inc.Avenue Therapeutics to Present at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual ConferenceNASDAQ:FBIOFortress Biotech Inc
20/06/202407:00GlobeNewswire Inc.Mustang Bio Announces $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq RulesNASDAQ:FBIOFortress Biotech Inc
17/06/202407:30GlobeNewswire Inc.Mustang Bio Announces Favorable Efficacy and Safety Data from Complete Waldenstrom Macroglobulinemia Cohort of Phase 1/2 Clinical Trial of MB-106, CD20-Targeted Autologous CAR-T TherapyNASDAQ:FBIOFortress Biotech Inc
16/05/202407:30GlobeNewswire Inc.Avenue Therapeutics Announces Last Patient Last Visit in Phase 1b/2a Clinical Trial of AJ201 for the Treatment of Spinal and Bulbar Muscular Atrophy (Kennedy's Disease)NASDAQ:FBIOFortress Biotech Inc
16/05/202407:00GlobeNewswire Inc.Fortress Biotech to Participate in the Alliance Global Partners’ (A.G.P.) Virtual Healthcare Company ShowcaseNASDAQ:FBIOFortress Biotech Inc
15/05/202415:15GlobeNewswire Inc.Fortress Biotech Reports First Quarter 2024 Financial Results and Recent Corporate HighlightsNASDAQ:FBIOFortress Biotech Inc
15/05/202415:01GlobeNewswire Inc.Journey Medical Corporation to Participate in the Alliance Global Partners’ (A.G.P.) Virtual Healthcare Company ShowcaseNASDAQ:FBIOFortress Biotech Inc
15/05/202407:30GlobeNewswire Inc.Avenue Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate HighlightsNASDAQ:FBIOFortress Biotech Inc
14/05/202407:30GlobeNewswire Inc.Fortress Biotech Announces First Patient Dosed in Multi-Center Phase 2 Study of Triplex for Control of CMV in Patients Undergoing Liver TransplantationNASDAQ:FBIOFortress Biotech Inc
13/05/202415:01GlobeNewswire Inc.Journey Medical Corporation Reports First Quarter 2024 Financial Results and Recent Corporate HighlightsNASDAQ:FBIOFortress Biotech Inc
07/05/202407:30GlobeNewswire Inc.Journey Medical Corporation to Announce First Quarter 2024 Financial Results on May 13, 2024NASDAQ:FBIOFortress Biotech Inc
02/05/202415:01GlobeNewswire Inc.Mustang Bio Announces Closing of $4 Million Public OfferingNASDAQ:FBIOFortress Biotech Inc
01/05/202415:01GlobeNewswire Inc.Journey Medical Corporation Appoints Joseph Benesch as Chief Financial OfficerNASDAQ:FBIOFortress Biotech Inc
29/04/202419:00GlobeNewswire Inc.Mustang Bio Announces Pricing of $4 Million Public OfferingNASDAQ:FBIOFortress Biotech Inc
29/04/202407:00GlobeNewswire Inc.Avenue Therapeutics Announces Exercise of Warrants for $4.4 Million in Gross ProceedsNASDAQ:FBIOFortress Biotech Inc
25/04/202407:30GlobeNewswire Inc.Journey Medical Corporation to Present at the Planet MicroCap Showcase: Vegas 2024NASDAQ:FBIOFortress Biotech Inc
24/04/202406:30GlobeNewswire Inc.Avenue Therapeutics Announces Reverse Stock SplitNASDAQ:FBIOFortress Biotech Inc
 Showing the most relevant articles for your search:NASDAQ:FBIO

Su Consulta Reciente

NASDAQ
AAPL
Apple
AMEX
SPY
SPDR S&P 500
NASDAQ
NVDA
NVIDIA
FX
EURMXN
Euro vs MXN
USOTC
DTEGY
Deutsche Telekom (QX)
COIN
AVAXUSD
Avalanche
USOTC
BASFY
BASF (QX)
NYSE
KO
Coca Cola
CCOM
SILVER
SILVER
USOTC
BNPQY
BNP Paribas (QX)
NYSE
NKE
Nike
USOTC
ADDYY
Adidas (QX)
FX
EURUSD
Euro vs US Dollar
NYSE
VZ
Verizon Communications
NASDAQ
MSFT
Microsoft
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados